2014
DOI: 10.1016/j.ejmech.2014.01.053
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of 2-methoxy-3-phenylsulfonamino-5-(quinazolin-6-yl or quinolin-6-yl)benzamides as novel PI3K inhibitors and anticancer agents by bioisostere

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(12 citation statements)
references
References 23 publications
1
11
0
Order By: Relevance
“…The values listed in Table 6 display the comparison of the solubility of S 1 , S 2 , and S 3 in each solvent. The results revealed that in different solvents except acetone and ethyl acetate, the solubility of S 2 was the highest and that of S 3 was the lowest; however, S 1 had the medium solubility, which was consistent with the antiproliferative activity demonstrated in our previous study [3]. The solubility of S 2 was the highest and that of S 1 was the lowest in acetone.…”
Section: Resultssupporting
confidence: 92%
See 2 more Smart Citations
“…The values listed in Table 6 display the comparison of the solubility of S 1 , S 2 , and S 3 in each solvent. The results revealed that in different solvents except acetone and ethyl acetate, the solubility of S 2 was the highest and that of S 3 was the lowest; however, S 1 had the medium solubility, which was consistent with the antiproliferative activity demonstrated in our previous study [3]. The solubility of S 2 was the highest and that of S 1 was the lowest in acetone.…”
Section: Resultssupporting
confidence: 92%
“…Compounds S 1 (melting point: 168.5-170.5°C), S 2 (melting point: 146-147°C), and S 3 (melting point: 141-142°C) were synthesized in the laboratory during our previous study and the structures were confirmed by nuclear magnetic resonance spectroscopy and high resolution mass spectroscopy [3]. The methods for the synthesis of three compounds and the characterization of their structures have been described in detail in our published study.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Using our established system, we screened several series of compounds, including compounds labelled W (N-(prop-2-ynyl)-4-(substituted phenylcarbonylamino) benzamides) [21], compounds labelled K (2-arylisoquinoline-1, 3(2H, 4H)-diones [22], compounds labelled Z (N-aryl salicylamides) [23], compounds labelled X (diaryl urea) [24], and compounds labelled S (5-(2-aminobenzo[d] hiazole-6-yl)-2-methoxy-3-(phenylsulfonylamino) benzamides) [25]. …”
Section: Methodsmentioning
confidence: 99%
“…However, a definite demonstration that these enzymes are relevant in vivo is lacking as most published studies have only studied the effects of pan PI3K inhibitors, especially wortmannin and LY294002, in preclinical models of inflammation resolution. There are now many new selective PI3K inhibitors in development [60]. Whether such drugs with greater selectivity and safety profile will resolve inflammation in vivo needs to be studied.…”
Section: Signaling Molecules As Crucial Regulators Of the Resolutimentioning
confidence: 99%